These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9755828)

  • 1. Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiation.
    Teillaud JL; Gruel N; Moncuit J; Mishal Z; Fridman WH; Lampidis TJ; Tapiero H
    Biomed Pharmacother; 1998; 52(6):282-90. PubMed ID: 9755828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of doxorubicin on mouse hybridoma B cells: stimulation of immunoglobulin synthesis and secretion.
    Teillaud JL; Fourcade A; Huppert J; Fridman WH; Tapiero H
    Cancer Res; 1989 Sep; 49(18):5123-9. PubMed ID: 2788496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
    Burres NS; Myers MT; Sartorelli AC
    Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential actions of aclarubicin and doxorubicin: the role of topoisomerase I.
    Bridewell DJ; Finlay GJ; Baguley BC
    Oncol Res; 1997; 9(10):535-42. PubMed ID: 9507531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
    Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aclarubicin in subtoxic doses reduces doxorubicin cytotoxicity in human non-small cell lung adenocarcinoma (A549) and human hepatocellular carcinoma (HepG2) cells by decreasing DNA damage.
    Gajek A; Rogalska A; Koceva-Chyła A
    Toxicol In Vitro; 2019 Mar; 55():140-150. PubMed ID: 30579959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle related uptake, retention and toxicity of idarubicin, daunorubicin and doxorubicin.
    Minderman H; Linssen P; Wessels J; Haanen C
    Anticancer Res; 1993; 13(4):1161-5. PubMed ID: 8352539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flow cytometric analysis of the effect of THP-adriamycin on the cell cycle traverse of RPMI-8402 cells--comparison with adriamycin].
    Takamoto S; Ota K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1868-75. PubMed ID: 3707149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line.
    Serafim TL; Oliveira PJ; Sardao VA; Perkins E; Parke D; Holy J
    Cancer Chemother Pharmacol; 2008 May; 61(6):1007-18. PubMed ID: 17661039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
    Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
    Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.
    Shin DH; Choi KS; Park SA; Cho BS; Lee HS; Ryu JS; Kim TY; Lee CK; Song S; Chung YB
    Arch Pharm Res; 2008 Oct; 31(10):1355-61. PubMed ID: 18958428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
    Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells.
    Nagai K; Nagasawa K; Sadzuka Y; Tsujimoto M; Takara K; Ohnishi N; Yokoyama T; Fujimoto S
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):244-50. PubMed ID: 11935217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent effects of doxorubicin on cardiac gene expression.
    Boucek RJ; Miracle A; Anderson M; Engelman R; Atkinson J; Dodd DA
    J Mol Cell Cardiol; 1999 Aug; 31(8):1435-46. PubMed ID: 10423342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of doxorubicin on the expression of cyclin A in K-562 leukemia cell line.
    Grzanka A; Zuryń A; Styczyński J; Grzanka AA; Wisniewska H
    Neoplasma; 2005; 52(6):489-93. PubMed ID: 16284694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grade-dependent effects on cell cycle progression and apoptosis in response to doxorubicin in human bladder cancer cell lines.
    Stravopodis DJ; Karkoulis PK; Konstantakou EG; Melachroinou S; Lampidonis AD; Anastasiou D; Kachrilas S; Messini-Nikolaki N; Papassideri IS; Aravantinos G; Margaritis LH; Voutsinas GE
    Int J Oncol; 2009 Jan; 34(1):137-60. PubMed ID: 19082486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vivo antitumor activity of mitoxantrone and the flow cytometric analysis of its influence on cell cycle transition--comparison with doxorubicin and aclarubicin on ascitic hepatoma AH109A cells].
    Asamura M; Yokoyama M; Kanamaru R; Kikuchi H; Gamoh M; Okuno M; Yi CD; Wakui A
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3769-76. PubMed ID: 2596860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFkappaB activation and drug sensitivity in human neoplastic cells treated with anthracyclines.
    Gruber BM; Anuszewska EL; Bubko I; Kasprzycka-Guttman T; Misiewicz I; Skupińska K; Fokt I; Piebe W
    Acta Pol Pharm; 2008; 65(2):267-71. PubMed ID: 18666436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.